Study on the Use of Cinacalcet in Phosphocalcic Context.
Conditions:   Hyperparathyroidism, Secondary;   Hyperparathyroidism, Primary Intervention:   Other: Serum PTH concentrations results Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2019 Category: Research Source Type: clinical trials

Novel Combination Therapy for Osteoporosis in Men
Condition:   Male Osteoporosis Interventions:   Drug: Teriparatide or human parathyroid hormone (PTH) 1-34;   Drug: Cinacalcet;   Drug: placebo tablet;   Dietary Supplement: Calcium citrate tablet;   Dietary Supplement: Vitamin D3 Sponsors:   VA Office of Research and Development;   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2019 Category: Research Source Type: clinical trials

Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
Condition:   Primary Hyperparathyroidism Interventions:   Drug: Cinacalcet;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials

Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
Condition:   Primary Hyperparathyroidism Interventions:   Drug: Cinacalcet;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2018 Category: Research Source Type: clinical trials